Page 164 - CW E-Magazine (14-11-2023)
P. 164

News from Abroad


       ELECTRIC MOBILITY

       Solvay and Orbia ink JV deal to build PVDF facility

       in US

          Belgium’s Solvay and US-based                                   mobility. Our partnership with Orbia
       Orbia’s Fluorinated Solutions business                             puts us in the driving seat to shore up
       have signed a joint venture (JV)                                   an independent, sustainable EV battery
       agreement to create “the largest” poly-                            supply chain in North  America and
       vinylidene fluoride (PVDF) production                              create clean energy jobs.”
       facilities  for battery materials  in the
       North America region.                                                 “Our partnership with Solvay under-
                                                                          scores our continued commitment  to
          Orbia and Solvay intend  to use                                 enabling the clean energy transition
       two  production sites: one in Augusta,   innovations  and Orbia’s raw material  with our investments  in energy mate-
       Georgia  (USA)  for  finished  products;  assets and production expertise will  rials. Orbia has a unique ‘mine-to-
       and one in St. Gabriel, Louisiana (USA)  enable delivery of PVDF that enables  market’  position  with  integration  in
       for raw material conversion to needed  electric vehicles to go farther on each  key battery materials needed to bolster
       intermediates. Both plants are expected  charge, extends battery life and im-  North America’s EV supply chain and
       to be operational in 2026. “This part-  proves battery safety. With more than  be IRA-compliant,” said Mr. Sameer
       nership brings security of supply with  half of US car sales projected to be elec-  Bharadwaj, CEO, Orbia.
       Inflation Reduction Act (IRA) compli-  tric by 2030, the US produced PVDF –
       ant materials and leading-edge  PVDF  a  thermoplastic  fluoropolymer  –  will    Solvay said it has also finalised an
       technology together for  solutions that  allow supply for the rapidly growing EV   agreement  with the U.S.  Department
       are critical to the North American elec-  battery market, meeting  the growing  of  Energy’s  Office  of  Manufacturing
       tric vehicle (EV) transition,” the com-  needs of US  domestic energy storage  and Energy Supply Chains for a $178-
       panies said.                      markets. The new operations will pro-  mn grant  to Solvay to help  build  this
                                         vide material  for more than 5 million  facility at its site in Augusta. The grant
          The partnership secures the sup-  EV batteries per year at full capacity  was awarded to Solvay as part of the
       ply by Orbia of materials for Solvay  and create hundreds of jobs throughout  U.S. Infrastructure Investment and Jobs
       to manufacture  its suspension-grade  the value chain, the companies said.  Act (IIJA) to expand U.S. domestic
       PVDF production, which is used as a                                manufacturing of batteries for electric
       lithium-ion binder and separator coat-  Ms. Ilham Kadri, CEO of Solvay,  vehicles and the electrical grid – as the
       ing in EV batteries. Solvay will bring  said, “We are proud  of  this important  project will fill a significant supply gap,
       its process technology and global mar-  project, which is a key milestone in our  building upon favourable regulatory
       ket know-how to this venture. In combi-  electrification  strategy,  emphasising  conditions that promote regional pro-
       nation, Solvay’s  Solef branded PVDF  our global  commitment  to sustainable  duction and material security.

       Noramco acquires Cambrex’s drug product

       business unit

          Noramco, a US-based active  Purisys, additional service options    “This acquisition allows Noramco
       pharmaceutical ingredients (API)  such as drug product formulation   to provide our  customers with more
       manufacturer, specialising in con-  development, clinical  and  commercial   sourcing  options  beyond APIs.  With
       trolled substances, has completed   drug product manufacturing, and  these additional capabilities, Noramco/
       the acquisition of the Cambrex drug  packaging from facilities in Mirabel,  Purisys  customers can develop drug
       product business unit previously   Québec and Whippany, New Jersey.  product formulations for  their  APIs
       known as  Halo  Phamaceuticals.  The   Noramco is returning to the Halo  for both clinical  and commercial  pur-
       acquisition will provide API customers   Pharmaceutical brand as part of this  poses,” said Noramco’s CEO, Mr. Lee
       of  Noramco, and  its subsidiary  acquisition.                     Karras.

       164                                                                 Chemical Weekly  November 14, 2023


                                      Contents    Index to Advertisers    Index to Products Advertised
   159   160   161   162   163   164   165   166   167   168   169